4//SEC Filing
Finizio Robert G 4
Accession 0001387131-20-005580
CIK 0000025743other
Filed
Jun 9, 8:00 PM ET
Accepted
Jun 10, 4:06 PM ET
Size
8.4 KB
Accession
0001387131-20-005580
Insider Transaction Report
Form 4
Finizio Robert G
DirectorChief Executive Officer10% Owner
Transactions
- Purchase
Common Stock
2020-06-09$1.47/sh+25,000$36,750→ 18,401,964 total - Purchase
Common Stock
2020-06-09$1.41/sh+21,000$29,610→ 18,376,964 total
Holdings
- 995,059(indirect: See Footnote)
Common Stock
- 1,004,941(indirect: See Footnote)
Common Stock
Footnotes (3)
- [F1]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.46 to $1.47, inclusive. The reporting person undertakes to provide to TherapeuticsMD, Inc., any security holder of TherapeuticsMD, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in Footnote (1) to this Form 4.
- [F2]The reported securities are owned by the reporting person's Grantor-Retained Annuity Trust.
- [F3]The reported securities are owned by Robert Finizio Revocable Trust.
Documents
Issuer
TherapeuticsMD, Inc.
CIK 0000025743
Entity typeother
Related Parties
1- filerCIK 0001532235
Filing Metadata
- Form type
- 4
- Filed
- Jun 9, 8:00 PM ET
- Accepted
- Jun 10, 4:06 PM ET
- Size
- 8.4 KB